Rainbow Coral Corp (OTCMKTS:RBCC) On The Rise Again

[[tagnumber 0]][[tagnumber 1]]The last time we wrote about Rainbow Coral Corp (OTCMKTS:RBCC) was back in the end of last month when the ticker was going through a rough period. It had just blasted through the charts, climbing from around 50 cents in the beginning of July to over $6 per share in the second half of the month, right before quickly descending down the charts.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We discussed the main reason for the increase in both price and daily volumes in our previous article, so the fact that the company was hovering around the $1.50 per share mark earlier this month isn’t surprising. What is surprising, however, is the stock’s latest upward run, especially when considering that their financial report for the quarter ended June 30, 2015, which was filed yesterday, contained the following numbers.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 9]] [[tagnumber 10]]cash: $2,740[[tagnumber 11]] [[tagnumber 10]]current assets: $4,524[[tagnumber 11]] [[tagnumber 10]]current liabilities: $517,798[[tagnumber 11]] [[tagnumber 10]]quarterly revenues: $27,683[[tagnumber 11]] [[tagnumber 10]]quarterly net loss: $136,929[[tagnumber 11]] [[tagnumber 20]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Now, in the interest of fairness, we must note that the report was filed late in the day and couldn’t affect the movement of the stock which registered another 9.27% gain and closed at $2.24 per share, finishing its fifth consecutive session in the green.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The interesting thing is that, it appears people who are trading the stock and aiding its recent climb might have overlooked some things and be running only on PR hype. The reason for this belief is the fact that [[tagnumber 28]]RBCC’s[[tagnumber 29]] run is fueled, once again, by fluff PR concerning their [[tagnumber 30]]“flagship”[[tagnumber 31]] product Naltrexone, which is used for treatment of alcohol and opioid dependence.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We would like to remind you that [[tagnumber 28]]RBCC[[tagnumber 29]] operates a fish store in Venice, Florida and take note that such a drug is mentioned absolutely nowhere in any of its recent filings with the SEC. This makes the whole “[[tagnumber 30]]biotech company[[tagnumber 31]]” deal sound a bit [[tagnumber 30]]“fishy”,[[tagnumber 31]] so you should be sure to do your due diligence and weigh out the risks before putting any money on the line.[[tagnumber 2]]